Search Results - "Soza-Ried C"

Author Correction: Antagonistic interactions safeguard mitotic propagation of genetic and epigenetic information in zebrafish.

Authors: Lawir DF Soza-Ried C Iwanami N et al.

Source: Communications biology [Commun Biol] 2024 Feb 29; Vol. 7 (1), pp. 247. Date of Electronic Publication: 2024 Feb 29.

Publication Type: Published Erratum

Journal Info: Publisher: Nature Publishing Group UK Country of Publication: England NLM ID: 101719179 Publication Model: Electronic Cited Medium: Internet ISSN: 2399-3642 (Electronic) Linking ISSN: 23993642 NLM ISO Abbreviation: Commun Biol Subsets: MEDLINE; PubMed not MEDLINE

Author Correction: Genetic landscape of T cells identifies synthetic lethality for T-ALL.

Authors: O'Meara CP Guerri L Lawir DF et al.

Source: Communications biology [Commun Biol] 2024 Feb 14; Vol. 7 (1), pp. 182. Date of Electronic Publication: 2024 Feb 14.

Publication Type: Published Erratum

Journal Info: Publisher: Nature Publishing Group UK Country of Publication: England NLM ID: 101719179 Publication Model: Electronic Cited Medium: Internet ISSN: 2399-3642 (Electronic) Linking ISSN: 23993642 NLM ISO Abbreviation: Commun Biol Subsets: MEDLINE; PubMed not MEDLINE

Safety and efficacy of [¹⁷⁷Lu]Lu-SibuDAB in patients with progressive metastatic castration-resistant prostate cancer.

Authors: Fernández R Soza-Ried C Kramer V et al.

Source: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2026 Mar; Vol. 53 (4), pp. 2282-2294. Date of Electronic Publication: 2025 Nov 07.

Publication Type: Journal Article

Journal Info: Publisher: Springer-Verlag Berlin Country of Publication: Germany NLM ID: 101140988 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1619-7089 (Electronic) Linking ISSN: 16197070 NLM ISO Abbreviation: Eur J Nucl Med Mol Imaging Subsets: MEDLINE

Biodistribution and dosimetry of [¹⁷⁷Lu]Lu-SibuDAB in patients with metastatic castration-resistant prostate cancer.

Authors: Ritt P Fernández R Soza-Ried C et al.

Source: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2025 Jun; Vol. 52 (7), pp. 2431-2443. Date of Electronic Publication: 2025 Feb 03.

Publication Type: Journal Article

Journal Info: Publisher: Springer-Verlag Berlin Country of Publication: Germany NLM ID: 101140988 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1619-7089 (Electronic) Linking ISSN: 16197070 NLM ISO Abbreviation: Eur J Nucl Med Mol Imaging Subsets: MEDLINE

The analysis of biodistribution and tumor uptake of [¹⁸F]AlF-FAPI-74 in patients with soft tissue sarcoma and gastro-intestinal tumors compared with [¹⁸F]FDG in a prospective, exploratory study.

Authors: Novruzov E Giesel FL Mamlins E et al.

Source: EJNMMI reports [EJNMMI Rep] 2026 Mar 06; Vol. 10 (1). Date of Electronic Publication: 2026 Mar 06.

Publication Type: Journal Article

Journal Info: Publisher: Springer Nature Country of Publication: England NLM ID: 9918752082606676 Publication Model: Electronic Cited Medium: Internet ISSN: 3005-074X (Electronic) Linking ISSN: 3005074X NLM ISO Abbreviation: EJNMMI Rep Subsets: PubMed not MEDLINE

PSMA PET in Lymph Node Staging of Prostate Cancer: From Diagnostic Accuracy to Clinical Decision-Making.

Authors: Esperto, Francesco Pischetola, Arianna Bauckneht, Matteo et al.

Source: Cancers. Jul2026, Vol. 18 Issue 13, p2094. 19p.

CT Radiomics Models Did Not Outperform Experts in Predicting [ 68 Ga]Ga-PSMA-PET Positivity in Prostate Cancer Lymph Node Staging.

Authors: Walter-Rittel, Thula Cannon Gorodetski, Boris Hartenstein, Alexander et al.

Source: Current Oncology. Mar2026, Vol. 31 Issue 3, p146. 16p.

FAPI Tracer en Vogue : Evaluating [ 68 Ga]Ga-DATA 5m.SA.FAPi for Molecular Imaging of Pulmonary Fibrosis.

Authors: Weissenböck, Victoria Schlederer, Michaela Bakiri, Latifa et al.

Source: Pharmaceuticals (14248247). Jan2026, Vol. 19 Issue 1, p34. 16p.

¹⁸F-FAPI PET/CT imaging in pneumoconiosis: a pilot study on a novel tool for early diagnosis and guiding the treatment of pulmonary fibrosis.

Authors: Liu, Chaofeng Guo, Zhongyuan Shi, Yiwei et al.

Source: EJNMMI Research. 12/22/2025, Vol. 15 Issue 1, p1-14. 14p.

The additive value of ⁶⁸Ga-RM26 PET/CT to ⁶⁸Ga-PSMA−617 PET/CT in assessing Post-treatment outcomes of ARSIs in mCRPC patients.

Authors: Liu, Xuhao Qi, Lin Gao, Xiaomei et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Dec2025, Vol. 53 Issue 1, p218-230. 13p.

Comparison of inter- and intraobserver agreement between [¹⁸F]AlF-NOTA-octreotide and [⁶⁸Ga]Ga-DOTA-SSA PET/CT.

Authors: Leupe, Hannes Ahmadi Bidakhvidi, Niloefar Goffin, Karolien et al.

Source: EJNMMI Reports. 5/15/2025, Vol. 9 Issue 1, p1-15. 15p.

A machine learning enhanced EMS mutagenesis probability map for efficient identification of causal mutations in Caenorhabditis elegans.

Authors: Guo, Zhengyang Wang, Shimin Wang, Yang et al.

Source: PLoS Genetics. 8/26/2024, Vol. 20 Issue 8, p1-21. 21p.

Fibroblast Activation Protein Inhibitor (FAPI) PET: A Scoping Review of Emerging Oncologic and Fibroinflammatory Applications.

Authors: Panagiotidis, Emmanouil Koinis, Filippos Zhang-Yin, Jules et al.

Source: Diagnostics (2075-4418). May2026, Vol. 16 Issue 10, p1542. 33p.

First-in-human study of dosimetry, safety and efficacy for [¹⁷⁷Lu]Lu-P15-073: a novel bisphosphonate-based radioligand therapy (RLT) agent for bone metastases.

Authors: Zhao, Ruiyue Lv, Jie Li, Mingzhao et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Feb2025, Vol. 52 Issue 3, p925-935. 11p.

First-in-Human PET Imaging of Prostate Cancer Using [⁶⁸Ga]Ga-AZ-093 and Its Nitroimidazole-Conjugated Derivative [⁶⁸Ga]Ga-AZ-NI-093.

Authors: Wang, Guochang Lai, Yuxin Chen, Dongning et al.

Source: Journal of Nuclear Medicine. Jan2026, Vol. 67 Issue 1, p105-112. 8p.

Enhancing the diagnostic capacity of [¹⁸F]PSMA-1007 PET/MRI in primary prostate cancer staging with artificial intelligence and semi-quantitative DCE: an exploratory study.

Authors: Glemser, Philip Alexander Freitag, Martin Kovacs, Balint et al.

Source: EJNMMI Reports. 11/8/2024, Vol. 8 Issue 1, p1-12. 12p.

Comparison of 68Ga-FAPI-04 and 68Ga-PSMA in a Case of Interstitial Lung Disease.

Authors: Önner, Hasan Kılınçer, Abidin

Source: Molecular Imaging & Radionuclide Therapy. 2025, Vol. 34 Issue 2, p1-3. 3p.

The Role of Robot-Assisted, Imaging-Guided Surgery in Prostate Cancer Patients.

Authors: Quarta, Leonardo Cannoletta, Donato Pellegrino, Francesco et al.

Source: Cancers. May2025, Vol. 17 Issue 9, p1401. 16p.

Clinical impact of using [¹⁸F]AlF‐NOTA‐octreotide PET/CT instead of [⁶⁸Ga]Ga‐DOTA‐SSA PET/CT: Secondary endpoint analysis of a multicenter, prospective trial.

Authors: Leupe, Hannes Pauwels, Elin Vandamme, Timon et al.

Source: Journal of Neuroendocrinology. Aug2024, Vol. 36 Issue 8, p1-9. 9p.

Efficacy, Safety, Blood Kinetics, and ²¹³Bi Distribution Studies of [²²⁵Ac]Ac-SibuDAB in Prostate Cancer Patients.

Authors: Schmitl, Stefan Kretschmer-Chott, Elisabeth Patronas, Eva-Maria et al.

Source: Journal of Nuclear Medicine. Aug2025, Vol. 66 Issue 8, p1239-1244. 6p.